Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pivonello

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Journal of Endocrinological Investigation|August 18, 2001
In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological featuresD Ferone, D J Kwekkeboom, R Pivonello, et al.
Journal of Endocrinological Investigation|April 29, 1999
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomasA Colao, S Lastoria, D Ferone, et al.
Clinical Endocrinology|April 25, 2001
In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphyD Ferone, R Pivonello, S Lastoria, et al.
Clinical Endocrinology|July 17, 1998
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's diseaseC Di Somma, A Colao, R Pivonello, et al.
Journal of Endocrinological Investigation|July 25, 2007
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patientsA Colao, R Pivonello, L Spinelli, et al.
Journal of Endocrinological Investigation|January 27, 2009
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: a retrospective, comparative, head-to-head studyR S Auriemma, R Pivonello, M Galdiero, et al.
Journal of Endocrinological Investigation|June 13, 1998
Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administrationA Colao, R Pivonello, D Ferone, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegalyA Colao, M De Rosa, R Pivonello, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
The metabolic profile in active acromegaly is gender-specificA Ciresi, M C Amato, R Pivonello, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cureA Colao, R Pivonello, S Spiezia, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Journal of Endocrinological Investigation|August 18, 2001
In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological featuresD Ferone, D J Kwekkeboom, R Pivonello, et al.
Journal of Endocrinological Investigation|April 29, 1999
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomasA Colao, S Lastoria, D Ferone, et al.
Clinical Endocrinology|April 25, 2001
In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphyD Ferone, R Pivonello, S Lastoria, et al.
Clinical Endocrinology|July 17, 1998
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's diseaseC Di Somma, A Colao, R Pivonello, et al.
Journal of Endocrinological Investigation|July 25, 2007
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patientsA Colao, R Pivonello, L Spinelli, et al.
Journal of Endocrinological Investigation|January 27, 2009
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: a retrospective, comparative, head-to-head studyR S Auriemma, R Pivonello, M Galdiero, et al.
Journal of Endocrinological Investigation|June 13, 1998
Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administrationA Colao, R Pivonello, D Ferone, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegalyA Colao, M De Rosa, R Pivonello, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
The metabolic profile in active acromegaly is gender-specificA Ciresi, M C Amato, R Pivonello, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cureA Colao, R Pivonello, S Spiezia, et al.
Pageof 14